(Q84615573)

English

FLT3 Mutations at Diagnosis and Relapse in Acute Myeloid Leukemia: Cytogenetic and Pathologic Correlations, Including Cuplike Blast Morphology

scientific article published on 01 August 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670134%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

FLT3 mutations at diagnosis and relapse in acute myeloid leukemia: cytogenetic and pathologic correlations, including cuplike blast morphology (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670134%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

FLT3 Mutations at Diagnosis and Relapse in Acute Myeloid Leukemia: Cytogenetic and Pathologic Correlations, Including Cuplike Blast Morphology (English)

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Nilanjana Banerji

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670134%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Stanley R. McCormick

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670134

13 June 2024

Matthew J. McCormick

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670134

13 June 2024

Patricia S. Grutkoski

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670134

13 June 2024

Gregory S. Ducker

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670134

13 June 2024

Rodney R. Higgins

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670134

13 June 2024

John R. Mendiola

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670134

13 June 2024

John J. Reinartz

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670134

13 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20670134

13 June 2024

publication date

1 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670134%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

full work available at URL

http://meridian.allenpress.com/aplm/article-pdf/134/8/1143/2770041/2009-0292-oa_1.pdf

Portable Document Format

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Archives of Pathology & Laboratory Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670134%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

134

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670134%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670134%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1143-1151

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670134%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

2

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Adult acute myeloid leukemia

3

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia

4

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

The structural basis for autoinhibition of FLT3 by the juxtamembrane domain

6

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product

7

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain

8

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

FLT3 mutations in acute myeloid leukemia cell lines

9

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

10

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis

11

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia

12

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications

13

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients

14

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type

15

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

16

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

17

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Flt3 mutations and leukaemia

18

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials.

19

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutation

20

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

The roles of FLT3 in hematopoiesis and leukemia

21

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Normal and oncogenic FLT3

22

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Risk assessment in patients with acute myeloid leukemia and a normal karyotype

23

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication

24

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients

25

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system

26

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse

27

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Heterogeneous patterns of FLT3 Asp(835) mutations in relapsed de novo acute myeloid leukemia: a comparative analysis of 120 paired diagnostic and relapse bone marrow samples

28

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene.

29

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibit

30

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Acute myelogenous leukemia with internal tandem duplication of the Flt3 gene appearing or altering at the time of relapse: a report of two cases.

31

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples

32

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Evolution of FLT3-ITD and D835 activating point mutations in relapsing acute myeloid leukemia and response to salvage therapy

33

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemia

34

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia

35

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy

37

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia

38

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

39

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations ("cuplike" nuclei)

40

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)

41

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

42

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412.

43

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability

44

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival

46

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Cup-like acute myeloid leukemia: new disease or artificial phenomenon?

47

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Acute myeloid leukemia with cuplike nuclei and intracytoplasmic inclusions following myelodysplastic syndrome

48

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

49

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation.

50

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features

51

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

52

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

53

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia

54

1 reference

10.5858/2009-0292-OA.1

https://api.crossref.org/works/10.5858/2009-0292-OA.1

13 June 2024

Identifiers

10.5858/2009-0292-OA.1

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20670134

13 June 2024

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670134%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84615573&oldid=2180240836"